Arrowhead Pharmaceuticals Stock Price and Value Analysis

Should you buy Arrowhead Pharmaceuticals stock? (NasdaqGS:ARWR). Let's see how it does in our automated value investing analysis system.

  • This company is less known than others.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company is not making money.
  • This company pays no dividend.

Inside the ARWR Numbers

ARWR Price
(Arrowhead Pharmaceuticals stock price per share)
[?] PE Ratio versus Sector 327% higher than other Healthcare stocks
[?] PE Ratio versus Industry 49% higher than other Biotechnology stocks
[?] Cash Yield -1.03%
[?] Free Cash Flow Jitter 98%

Is Arrowhead Pharmaceuticals Stock on Sale?

Based on our analysis, we believe that you should not buy Arrowhead Pharmaceuticals right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy ARWR Stock?

Does Arrowhead Pharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.